Dipyridamole-dobutamine stress with Tc-99m sestamibi tomographic myocardial perfusion imaging. 1998

A R Shehata, and A W Ahlberg, and M P White, and A Mann, and I A Fleming, and M G Levine, and J F Mather, and D Waters, and G V Heller
Division of Cardiology, Hartford Hospital, Connecticut 06102, USA.

In 66 patients unable to exercise referred for pharmacologic stress single-photon emission computed tomographic myocardial perfusion imaging, a moderate dose of dobutamine was combined with intravenous dipyridamole and the results were compared with standard intravenous dipyridamole stress. The combined stress protocol resulted in increased defect size and reversibility with technetium-99m sestamibi single-photon emission computed tomographic myocardial perfusion imaging.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002316 Cardiotonic Agents Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). Cardiac Stimulant,Cardiac Stimulants,Cardioprotective Agent,Cardioprotective Agents,Cardiotonic,Cardiotonic Agent,Cardiotonic Drug,Inotropic Agents, Positive Cardiac,Myocardial Stimulant,Myocardial Stimulants,Cardiotonic Drugs,Cardiotonics,Agent, Cardioprotective,Agent, Cardiotonic,Drug, Cardiotonic,Stimulant, Cardiac,Stimulant, Myocardial
D003331 Coronary Vessels The veins and arteries of the HEART. Coronary Arteries,Sinus Node Artery,Coronary Veins,Arteries, Coronary,Arteries, Sinus Node,Artery, Coronary,Artery, Sinus Node,Coronary Artery,Coronary Vein,Coronary Vessel,Sinus Node Arteries,Vein, Coronary,Veins, Coronary,Vessel, Coronary,Vessels, Coronary
D004176 Dipyridamole A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752) Antistenocardin,Apo-Dipyridamole,Cerebrovase,Cléridium,Curantil,Curantyl,Dipyramidole,Kurantil,Miosen,Novo-Dipiradol,Persantin,Persantine,Apo Dipyridamole,Novo Dipiradol
D004280 Dobutamine A catecholamine derivative with specificity for BETA-1 ADRENERGIC RECEPTORS. It is commonly used as a cardiotonic agent after CARDIAC SURGERY and during DOBUTAMINE STRESS ECHOCARDIOGRAPHY. Dobucor,Dobuject,Dobutamin Fresenius,Dobutamin Hexal,Dobutamin Solvay,Dobutamin-ratiopharm,Dobutamina Inibsa,Dobutamina Rovi,Dobutamine (+)-Isomer,Dobutamine Hydrobromide,Dobutamine Hydrochloride,Dobutamine Lactobionate,Dobutamine Phosphate (1:1) Salt, (-)-Isomer,Dobutamine Tartrate,Dobutamine Tartrate (1:1), (R-(R*,R*))-Isomer,Dobutamine Tartrate (1:1), (S-(R*,R*))-Isomer,Dobutamine, (-)-Isomer,Dobutamine, Phosphate (1:1) Salt (+)-Isomer,Dobutrex,Lilly 81929,Oxiken,Posiject,Dobutamin ratiopharm,Hydrobromide, Dobutamine,Hydrochloride, Dobutamine,Lactobionate, Dobutamine,Tartrate, Dobutamine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D014665 Vasodilator Agents Drugs used to cause dilation of the blood vessels. Vasoactive Antagonists,Vasodilator,Vasodilator Agent,Vasodilator Drug,Vasorelaxant,Vasodilator Drugs,Vasodilators,Vasorelaxants,Agent, Vasodilator,Agents, Vasodilator,Antagonists, Vasoactive,Drug, Vasodilator,Drugs, Vasodilator

Related Publications

A R Shehata, and A W Ahlberg, and M P White, and A Mann, and I A Fleming, and M G Levine, and J F Mather, and D Waters, and G V Heller
January 1999, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology,
A R Shehata, and A W Ahlberg, and M P White, and A Mann, and I A Fleming, and M G Levine, and J F Mather, and D Waters, and G V Heller
August 2005, Prilozi,
A R Shehata, and A W Ahlberg, and M P White, and A Mann, and I A Fleming, and M G Levine, and J F Mather, and D Waters, and G V Heller
April 2015, The American journal of cardiology,
A R Shehata, and A W Ahlberg, and M P White, and A Mann, and I A Fleming, and M G Levine, and J F Mather, and D Waters, and G V Heller
January 1999, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology,
A R Shehata, and A W Ahlberg, and M P White, and A Mann, and I A Fleming, and M G Levine, and J F Mather, and D Waters, and G V Heller
March 2012, International journal of cardiology,
A R Shehata, and A W Ahlberg, and M P White, and A Mann, and I A Fleming, and M G Levine, and J F Mather, and D Waters, and G V Heller
February 2000, Clinical nuclear medicine,
A R Shehata, and A W Ahlberg, and M P White, and A Mann, and I A Fleming, and M G Levine, and J F Mather, and D Waters, and G V Heller
September 2006, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology,
A R Shehata, and A W Ahlberg, and M P White, and A Mann, and I A Fleming, and M G Levine, and J F Mather, and D Waters, and G V Heller
October 2003, Journal of the American College of Cardiology,
A R Shehata, and A W Ahlberg, and M P White, and A Mann, and I A Fleming, and M G Levine, and J F Mather, and D Waters, and G V Heller
July 2007, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology,
A R Shehata, and A W Ahlberg, and M P White, and A Mann, and I A Fleming, and M G Levine, and J F Mather, and D Waters, and G V Heller
January 2006, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology,
Copied contents to your clipboard!